☰

Mianen Sun, Ph.D. - Publications

Affiliations: 
2008 Cell Biology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Jonasch E, Sun M, Tong P, Kong W, Dong B, Huang Y, Park IY, Zhou L, Liu XD, Ding Z, Zhang X, Bai S, German P, Powell R, Wang Q, et al. HNF1B loss exacerbates the development of chromophobe renal cell carcinomas. Cancer Research. PMID 28807937 DOI: 10.1158/0008-5472.Can-17-0986  0.404
2016 Jonasch E, Hoang A, Sun M, Zhou L, Ding Z, Zhang X, Bai S, Tannir NM, Liu X. Sunitinib to upregulate IFNg-STAT1 signaling and to increase indoleamine 2,3-dioxygenase (IDO) expression in renal cell carcinoma (RCC). Journal of Clinical Oncology. 34: 614-614. DOI: 10.1200/Jco.2016.34.2_Suppl.614  0.435
2016 Liu X, Hoang A, Sun M, Lijun Z, Ding Z, Zhang X, Bai S, Tannir N, Jonasch E. Abstract A147: Sunitinib upregulates IFNγ-STAT1 signaling to modulate the tumor immune microenvironment in renal cell carcinoma Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-A147  0.453
2015 Zhou L, Liu XD, Sun M, Zhang X, German P, Bai S, Ding Z, Tannir N, Wood CG, Matin SF, Karam JA, Tamboli P, Sircar K, Rao P, Rankin EB, et al. Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene. PMID 26364599 DOI: 10.1038/Onc.2015.343  0.425
2015 Liu X, Hoang A, Zhou L, Kalra S, Yetil A, Sun M, Ding Z, Zhang X, Bai S, German P, Tamboli P, Rao P, Karam JA, Wood CG, Matin SF, et al. Resistance to anti-angiogenic therapy is associated with an immunosuppressive tumor microenvironment in metastatic renal cell carcinoma. Cancer Immunology Research. PMID 26014097 DOI: 10.1158/2326-6066.Cir-14-0244  0.334
2015 Liu XD, Yao J, Tripathi DN, Ding Z, Xu Y, Sun M, Zhang J, Bai S, German P, Hoang A, Zhou L, Jonasch D, Zhang X, Conti CJ, Efstathiou E, et al. Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis. Oncogene. 34: 2450-60. PMID 24998849 DOI: 10.1038/onc.2014.199  0.393
2015 Liu X, Hoang A, Zhou L, Kalra S, Yetil A, Sun M, Ding Z, Tamboli P, Rao P, Karam JA, Wood CG, Matin SF, Zurita AJ, Bex A, Griffioen AW, et al. Association of resistance to antiangiogenic therapy with an immunosuppressive tumor microenvironment in metastatic renal cell carcinoma. Journal of Clinical Oncology. 33: 419-419. DOI: 10.1200/Jco.2015.33.7_Suppl.419  0.34
2014 Ding Z, German P, Bai S, Reddy AS, Liu XD, Sun M, Zhou L, Chen X, Zhao X, Wu C, Zhang S, Mills GB, Jonasch E. Genetic and pharmacological strategies to refunctionalize the von Hippel Lindau R167Q mutant protein. Cancer Research. 74: 3127-36. PMID 24755468 DOI: 10.1158/0008-5472.Can-13-3213  0.331
2014 Zhang D, Wang H, Sun M, Yang J, Zhang W, Han S, Xu B. Speckle-type POZ protein, SPOP, is involved in the DNA damage response. Carcinogenesis. 35: 1691-7. PMID 24451148 DOI: 10.1093/Carcin/Bgu022  0.379
2014 Zhou L, Liu X, Sun M, Tannir NM, Laird D, Jonasch E. Abstract 687: The mechanisms of anti-VEGF therapy resistance in renal cell carcinoma Cancer Research. 74: 687-687. DOI: 10.1158/1538-7445.Am2014-687  0.431
2014 Liu X, Yao J, Tripathi DN, Ding Z, Xu Y, Sun M, Zhang J, Bai S, German P, Hoang A, Zhou L, Zhang X, Conti CJ, Efstathiou E, Eissa TN, et al. Abstract 312: Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis Cancer Research. 74: 312-312. DOI: 10.1158/1538-7445.Am2014-312  0.465
2014 Sun M, Monzon F, Zhou L, Liu X, Ding Z, Zhang X, Bai S, German P, Kalra S, Park IY, Dere R, Berry T, Tong X, Walker C, Tannir N, et al. Abstract 2224: Identification of molecular drivers of human hemangioblastoma Cancer Research. 74: 2224-2224. DOI: 10.1158/1538-7445.Am2014-2224  0.43
2013 Sun M, Zhou T, Jonasch E, Jope RS. DDX3 regulates DNA damage-induced apoptosis and p53 stabilization. Biochimica Et Biophysica Acta. 1833: 1489-97. PMID 23470959 DOI: 10.1016/J.Bbamcr.2013.02.026  0.635
2012 Sun M, Guo X, Qian X, Wang H, Yang C, Brinkman KL, Serrano-Gonzalez M, Jope RS, Zhou B, Engler DA, Zhan M, Wong ST, Fu L, Xu B. Activation of the ATM-Snail pathway promotes breast cancer metastasis. Journal of Molecular Cell Biology. 4: 304-15. PMID 22923499 DOI: 10.1093/Jmcb/Mjs048  0.559
2011 Gao Y, Ishiyama H, Sun M, Brinkman KL, Wang X, Zhu J, Mai W, Huang Y, Floryk D, Ittmann M, Thompson TC, Butler EB, Xu B, Teh BS. The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both in vitro and in vivo. Radiation Oncology (London, England). 6: 39. PMID 21496273 DOI: 10.1186/1748-717X-6-39  0.335
2011 Sun M, Song L, Zhou T, Gillespie GY, Jope RS. The role of DDX3 in regulating Snail. Biochimica Et Biophysica Acta. 1813: 438-47. PMID 21237216 DOI: 10.1016/J.Bbamcr.2011.01.003  0.61
2011 Guo X, Lei T, Sun M, Yang C, Fu L, Xu B. Abstract 2270: ATM is hyperactivated in triple-negative breast cancer tissues Cancer Research. 71: 2270-2270. DOI: 10.1158/1538-7445.Am2011-2270  0.417
2010 Sun M, Lin C, Tang X, Xu B. Abstract 3877: An inhibitor-2 complex regulates cell cycle checkpoints in response to DNA damage Cancer Research. 70: 3877-3877. DOI: 10.1158/1538-7445.Am10-3877  0.438
2010 Sun M, Zhou T, Gillespie Y, Xu B, Jope R. Abstract 2981: Regulation of Snail by DDX3 and ATM in response to DNA damage Cancer Research. 70: 2981-2981. DOI: 10.1158/1538-7445.Am10-2981  0.617
2010 Ishiyama H, Sun M, Gao Y, Danforth R, Wang H, Chunying Y, Brinkman K, Butler E, Xu B, The B. Perifosine (PI3K/AKT Inhibitor) Enhanced Radiation Anti-tumor Efficacy in Prostate Cancer: What is the Optimum Sequence and Timing of the Combined Approach? International Journal of Radiation Oncology*Biology*Physics. 78: S658-S659. DOI: 10.1016/J.Ijrobp.2010.07.1533  0.337
2009 Sun M, Meares G, Song L, Jope RS. XIAP associates with GSK3 and inhibits the promotion of intrinsic apoptotic signaling by GSK3. Cellular Signalling. 21: 1857-65. PMID 19698783 DOI: 10.1016/J.Cellsig.2009.08.002  0.602
2008 Sun M, Song L, Li Y, Zhou T, Jope RS. Identification of an antiapoptotic protein complex at death receptors. Cell Death and Differentiation. 15: 1887-900. PMID 18846110 DOI: 10.1038/Cdd.2008.124  0.583
Show low-probability matches.